Clinical Trials List
2024-07-01 - 2027-12-31
Phase I/II
Not yet recruiting4
Recruiting1
ICD-10C34.80
Malignant neoplasm of overlapping sites of unspecified bronchus and lung
ICD-10C34.81
Malignant neoplasm of overlapping sites of right bronchus and lung
ICD-10C34.82
Malignant neoplasm of overlapping sites of left bronchus and lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.8
Malignant neoplasm of other parts of bronchus or lung
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊政皓 無
- Inn-Wen Chong 無
- Jen-Yu Hung 無
- Ying-Ming Tsai Tsai 無
- 李玫萱 無
- KUAN-LI WU 無
- 郭家佑 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Seu-Chun Yang 無
- 林建佑 Division of General Internal Medicine
- Chun-Hui Lee 無
- Chin-Wei Kuo 無
- Shang-Yin Wu 無
- Chian-Wei Chen 無
- Wu-Chou Su 無
- 蔡政軒 無
- Po-Lan Su Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 趙恒勝 無
- Yung-Hung Luo 無
- 廖映庭 無
- Chi-Lu Chiang 無
- YEN-HAN TSENG 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
220 participants
